| Literature DB >> 29179882 |
Chidre Prabhurajeshwar1, Revanasiddappa Kelmani Chandrakanth2.
Abstract
BACKGROUND: Probiotics, live cells with different beneficiary characteristics, have been extensively studied and explored commercially in many different products in the world. Their benefits to human and animal health have proven in hundreds of scientific studies. Based on rich bibliographic material, Curd is the potential source of probiotic Lactobacilli.Entities:
Keywords: Antimicrobial activity; Bacteriocin; Curd; Lactic acid bacteria; Lactobacillus species
Mesh:
Substances:
Year: 2017 PMID: 29179882 PMCID: PMC6138816 DOI: 10.1016/j.bj.2017.06.008
Source DB: PubMed Journal: Biomed J ISSN: 2319-4170 Impact factor: 4.910
Fig. 1Typical characteristics of the isolates grown on MRS agar medium.
Morphological, cultural and biochemical characteristics of isolated Lactobacillus spp. from curd samples.
| Sl. No | Selected | Morphological and cultural characteristics | Gram's staining | Motility test | Catalase test | Carbohydrate fermentation test | |||
|---|---|---|---|---|---|---|---|---|---|
| Glucose | Sorbitol | Sucrose | |||||||
| Acid | Gas | ||||||||
| 1 | T1 | 1.0 mm white, rough, irregular and round | Gram +ve, bacilli | Non motile | Negative | +ve | −ve | −ve | −ve |
| 2 | T2 | Small, 0.1–0.5 mm, rough dull and round | Gram +ve, bacilli | Non motile | Negative | −ve | −ve | −ve | −ve |
| 3 | T3 | 1 mm, White, shiny smooth | Gram +ve, bacilli | Non motile | Negative | −ve | −ve | −ve | −ve |
| 4 | T4 | Small circular, white creamy | Gram +ve, bacilli | Non motile | Negative | −ve | −ve | −ve | −ve |
| 5 | T5 | 1.0 mm white, rough, irregular and round | Gram +ve, bacilli | Non motile | Negative | −ve | −ve | −ve | −ve |
| 6 | T6 | Small circular, white creamy | Gram +ve, bacilli | Non motile | Negative | +ve | −ve | −ve | −ve |
| 7 | T7 | Small, 0.1–0.5 mm, rough dull and round | Gram +ve, bacilli | Non motile | Negative | +ve | −ve | +ve | +ve |
| 8 | T8 | 1.0 mm white, rough, irregular and round | Gram +ve, bacilli | Non motile | Negative | +ve | −ve | +ve | +ve |
| 9 | T9 | Small circular, white creamy | Gram +ve, bacilli | Non motile | Negative | +ve | −ve | +ve | −ve |
| 10 | T10 | Small, 0.1–0.5 mm, rough dull and round | Gram +ve, bacilli | Non motile | Negative | +ve | −ve | +ve | +ve |
| 11 | T11 | Small circular, white creamy | Gram +ve, bacilli | Non motile | Negative | +ve | −ve | +ve | +ve |
| 12 | T12 | 1.0 mm white, rough, irregular and round | Gram +ve, bacilli | Non motile | Negative | +ve | −ve | +ve | +ve |
| 13 | T13 | Small, 0.1–0.5 mm, rough dull and round | Gram +ve, bacilli | Non motile | Negative | −ve | −ve | +ve | +ve |
| 14 | T14 | Small, irregular, smooth and circular | Gram +ve, bacilli | Non motile | Negative | +ve | −ve | −ve | +ve |
| 15 | T15 | Small circular, white creamy | Gram +ve, bacilli | Non motile | Negative | +ve | −ve | −ve | −ve |
| 16 | T16 | 1.0 mm white, rough, irregular and round | Gram +ve, bacilli | Non motile | Negative | −ve | −ve | +ve | −ve |
Fig. 2Microscopic observation of Gram's stained Lactobacillus spp.
Fig. 3Optimal growth and pH of isolated Lactobacillus isolates from curd samples.
Fig. 4Bile acid tolerance of Lactobacillus isolates from curd samples.
Fig. 5NaCl tolerance of Lactobacillus isolates from curd samples.
Fig. 6Phylogenetic tree based on Neighbour-joining method of 16s rRNA gene sequencing.
Fig. 7Antibiotic susceptibility pattern of Lactobacillus isolates.
Antibiotic susceptibility test for Lactobacillus isolates curd samples.
| Sl. No. | Antibiotics used | No. of resistance | No. of sensitive | No. of intermediate |
|---|---|---|---|---|
| 1 | Ampicillin | 10 (87.50%) | 3 (18.75%) | – |
| 2 | Amikacin | 5 (31.25%) | 11 (68.75%) | – |
| 3 | Amoxyclav | 5 (31.25%) | 11 (68.75%) | – |
| 4 | Cefuroxime | 6 (37.50%) | 9 (56.25%) | 1 (6.25%) |
| 5 | Cephalothin | 5 (31.25)% | 11 (68.75)% | – |
| 6 | Chloramphenicol | 8 (50%) | 8 (50%) | – |
| 7 | Ciprofloxacin | 7 (37.5%) | 10 (62.5%) | – |
| 8 | Clindamycin | 9 (56.25%) | 7 (43.75%) | – |
| 9 | Cotrimoxazole | 5 (31.25%) | 11 (68.75%) | – |
| 10 | Erythromycin | 5 (31.25%) | 11 (68.75%) | – |
| 11 | Gentamycin | 5 (31.25%) | 11 (68.75%) | – |
| 12 | Oxacillin | 16 (100%) | – | – |
| 13 | Sulfamethizole | 5 (31.25%) | 8 (50%) | 2 (12.5%) |
| 14 | Tetracycline | 7 (37.5%) | 10 (62.5%) | – |
| 15 | Vancomycin | 8 (50%) | 5 (18.75%) | 3 (31.25%) |
Fig. 8Antagonistic activity of Lactobacillus isolates against different test pathogens. (A) Gram-positive (B) Gram-negative.
Fig. 9Antagonistic activity of Lactobacillus isolates from Curd samples.
Antagonistic activity of Lactobacillus isolates against test pathogens from curd samples.
| Sl. No | Zone of inhibition in mm (from outer edge of | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | T1 | 21 | 19 | 18 | 22 | 14 | 18 | 19 |
| 2 | T2 | 24 | 24 | 24 | 35 | 24 | 20 | 24 |
| 3 | T3 | 19 | 16 | 22 | 23 | 18 | 18 | 12 |
| 4 | T4 | 24 | 22 | 28 | 26 | 23 | 21 | 21 |
| 5 | T5 | 17 | 14 | 24 | 19 | 14 | 19 | 14 |
| 6 | T6 | 22 | 19 | 20 | 21 | 17 | 19 | 23 |
| 7 | T7 | 19 | 20 | 18 | 18 | 20 | 15 | 13 |
| 8 | T8 | 16 | 21 | 17 | 13 | 21 | 17 | 19 |
| 9 | T9 | 14 | 21 | 14 | 20 | 20 | 19 | 17 |
| 10 | T10 | 14 | 16 | 20 | 20 | 20 | 12 | 18 |
| 11 | T11 | 19 | 16 | 22 | 18 | 17 | 14 | 20 |
| 12 | T12 | 22 | 14 | 20 | 19 | 18 | 13 | 20 |
| 13 | T13 | 20 | 19 | 19 | 20 | 19 | 11 | 18 |
| 14 | T14 | 14 | 18 | 16 | 19 | 20 | 21 | 17 |
| 15 | T15 | 20 | 19 | 14 | 18 | 22 | 22 | 14 |
| 16 | T16 | 30 | 23 | 23 | 22 | 26 | 25 | 24 |
Bacteriostatic and bactericidal activity of curd isolates (T2, T4 and T16).
| Name of the pathogens | T2 isolate | T4 isolate | T16 isolate |
|---|---|---|---|
| + | + | − | |
| + | + | − | |
| − | − | − | |
| − | − | − | |
| − | − | − | |
| − | + | − | |
| − | + | + |
+: Bacteriostatic; −: Bacteriocidal.
Fig. 10Antimicrobial activity of Lactobacillus (CFCS) Inhibitory substances against test pathogen. (A) Bacteriocin (B) Organic acid.
Characterization of antimicrobial substances of selected curd isolates.
| Sl. No. | T2 (in mm) | T4 (in mm) | T16 (in mm) | ||||
|---|---|---|---|---|---|---|---|
| Bacteriocin assay | Organic acid assay | Bacteriocin assay | Organic acid assay | Bacteriocin assay | Organic acid assay | ||
| 1 | 21 | – | – | 14 | – | 13 | |
| 2 | – | 19 | – | 13 | – | 12 | |
| 3 | 22 | – | – | 18 | – | 19 | |
| 4 | – | 23 | – | 17 | – | 17 | |
| 5 | 19 | – | – | 12 | – | 16 | |
| 6 | – | 21 | – | 18 | – | 21 | |
| 7 | – | 17 | – | 17 | – | 22 | |
Percentage of auto-aggregation of Probiotic selected isolates with pathogenic strains.
| Auto-aggregation (%) | |||
|---|---|---|---|
| 4 h | 18 h | 24 h | |
| T2 isolate | 23 ± 0.7 | 34 ± 0.2 | 51 ± 0.4 |
| T4 isolate | 17 ± 0.9 | 26 ± 0.8 | 40 ± 0.2 |
| T16 isolate | 13 ± 1.1 | 28 ± 1.2 | 48 ± 0.7 |
| 3.2 ± 1.0 | 4.2 ± 0.1 | 6.0 ± 0.9 | |
| 2.9 ± 1.4 | 3.6 ± 0.4 | 4.3 ± 0.8 | |
| 7.8 ± 1.2 | 14.1 ± 0.8 | 18 ± 1.2 | |
| 4.5 ± 0.8 | 12.1 ± 1.1 | 21 ± 1.5 | |
| 6.1 ± 1.1 | 13 ± 1.3 | 19 ± 1.1 | |
| 3.1 ± 0.8 | 11 ± 0.9 | 23 ± 0.1 | |
| 2.9 ± 0.4 | 10.8 ± 0.1 | 22 ± 1.0 | |
Percentage of cell-surface hydrophobicity of bacterial strains.
| Selected | % of co-aggregation with indicator strains | ||||||
|---|---|---|---|---|---|---|---|
| T2 isolate | 25.6 ± 2.2 | 12.8 ± 0.8 | 19.6 ± 0.8 | 16 ± 0.8 | 18 ± 1.8 | 23 ± 0.6 | 27.3 ± 6.2 |
| T4 isolate | 5.4 ± 4.2 | 11.4 ± 0.6 | 7.1 ± 1.2 | 3.6 ± 0.9 | 12 ± 0.8 | 10 ± 0.4 | 21.4 ± 5.9 |
| T16 isolate | 11.2 ± 1.8 | 18.57 ± 0.7 | 16.8 ± 0.6 | 10.2 ± 1.2 | 14 ± 1.2 | 14 ± 0.3 | 23.4 ± 1.8 |
Percentage of cell-surface hydrophobicity of bacterial strains.
| Selected strains | Cell-surface hydrophobicity (%) |
|---|---|
| T2 | 73.0 ± 0.6 |
| T4 | 37 ± 0.7 |
| T16 | 51 ± 1.2 |
| 9.1 ± 0.2 | |
| 4 ± 0.1 | |
| 28.4 ± 0.6 | |
| 20.6 ± 1.2 | |
| 10.1 ± 0.3 | |
| 19.4 ± | |
| 33.1 ± | |
Fig. 11Time kill assay of Lactobacillus (CFCS) isolate against test pathogen. (A) Reduction in pathogen colonies (B) Complete killing of pathogen colonies.
Quantification of organic acid and determination of pH value of selected Lactobacillus spp.
| Sources of bacteria | Name of the bacteria | Incubation time (Hour) | Incubation temp. (°C) | Organic acid (%) | pH |
|---|---|---|---|---|---|
| Curd | T2 ( | 12 | 37 | 0.2 | 5.47 |
| 24 | 37 | 0.28 | 5.11 | ||
| 48 | 37 | 0.31 | 4.91 | ||
| 72 | 37 | 0.33 | 4.62 | ||
| Curd | T4 | 12 | 37 | 0.12 | 5.36 |
| 24 | 37 | 0.22 | 5.23 | ||
| 48 | 37 | 0.21 | 4.72 | ||
| 72 | 37 | 0.30 | 4.51 | ||
| Curd | T16 | 12 | 37 | 0.21 | 5.8 8 |
| 24 | 37 | 0.23 | 5.34 | ||
| 48 | 37 | 0.29 | 4.92 | ||
| 72 | 37 | 0.31 | 4.45 |
Fig. 12Scanning Electron Microscopy images. (A) Control. (B) Treated with Lactobacillus isolate (CFCS).